Clinical Trials Directory

Trials / Completed

CompletedNCT06636643

The Effect of Bone Marrow Stem Cells Harvested from the Iliac Crest Versus Mandibular Ramus in Alveolar Cleft Regeneration

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
Faculty of Dental Medicine for Girls · Other Government
Sex
All
Age
Healthy volunteers
Accepted

Summary

This comparative and prospective study was conducted on 10 patients with alveolar cleft defects. Patients with alveolar cleft defects were randomly selected and randomly divided into two equal groups: Group A: received Autologous (BMMSCs) harvested from the mandibular ramus and seeded on a collagen sponge in combination with nanohydroxyapatite. Group B: received Autologous (BMMSCs) harvested from the lilac crest and seeded on a collagen sponge in combination with nanohydroxyapatite.

Detailed description

The utilization of Mandibular Ramus-derived BMSCs presents a groundbreaking advancement in maxillofacial reconstruction. This approach offers numerous advantages, including reduced surgical complications, improved precision and localization, higher osteogenic potential, and lower risks of graft rejection. Moreover, the combination of BMMNCs, nanohydroxyapatite, and PRF extracted from the mandible proves to be a viable alternative to traditional iliac crest grafting, promoting effective bone regeneration in alveolar cleft defects. By adopting this novel technique and harvesting site, It can can optimize surgical interventions, paving the way for enhanced standards of care and improving the quality of life for patients with maxillofacial challenges

Conditions

Timeline

Start date
2021-04-15
Primary completion
2021-05-20
Completion
2024-05-29
First posted
2024-10-10
Last updated
2024-10-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06636643. Inclusion in this directory is not an endorsement.